NCT04268732

Brief Summary

A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in differentiating bacterial from viral infection among acute febrile patients in Gondar, northwest Ethiopia.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 13, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

May 11, 2021

Status Verified

May 1, 2021

Enrollment Period

3 months

First QC Date

February 11, 2020

Last Update Submit

May 10, 2021

Conditions

Keywords

biomarkersbacterial infectionviral infectionmalarial infection

Outcome Measures

Primary Outcomes (1)

  • The differentiation of bacterial infections and viral infections among acute febrile patients with biomarkers

    CRP (bacterial biomarker) and MxA (viral biomarker) will be evaluated for differentiating confirmed bacterial and viral infections.

    within 7 days after onset of fever

Secondary Outcomes (3)

  • The number of malaria cases, bacterial infections, viral infections and unknown etiologies among acute febrile patients in Gondar

    within 7 days after onset of fever

  • The comparison of different assays for diagnosis of DENV

    within 7 days after onset of fever

  • The comparison of the qualitative and qualitative detection of CRP for differentiating bacterial and viral infections

    within 7 days after onset of fever

Eligibility Criteria

Age15 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients ≥ 15 years old with acute undifferentiated fever and seeking health services within 7 days after fever onset at the emergency ward of the university of Gondar hospital (Ethiopia) during the study period.

You may qualify if:

  • Patients presenting with acute fever (an axillary temperature of ≥37.5°C; symptom duration ≤7 days)
  • ≥ 15 years old
  • signed informed consent

You may not qualify if:

  • pregnant woman \& children (\<15 y)
  • febrile patient suspected of urinary tract infection or acute respiratory tract infection
  • Individuals who had taken antimicrobial and antimalarial drug in the last 2 weeks
  • Patients with acute injury or trauma or for which participation in the study implies an unacceptable health risk as determined by the physicians

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute of Tropical Medicine

Antwerp, 2000, Belgium

Location

University of Gondar

Gonder, Ethiopia

Location

Related Publications (7)

  • Bhargava A, Ralph R, Chatterjee B, Bottieau E. Assessment and initial management of acute undifferentiated fever in tropical and subtropical regions. BMJ. 2018 Nov 29;363:k4766. doi: 10.1136/bmj.k4766. No abstract available.

    PMID: 30498133BACKGROUND
  • Mohammed Yusuf A, Abdurashid Ibrahim N. Knowledge, attitude and practice towards dengue fever prevention and associated factors among public health sector health-care professionals: in Dire Dawa, eastern Ethiopia. Risk Manag Healthc Policy. 2019 Jun 7;12:91-104. doi: 10.2147/RMHP.S195214. eCollection 2019.

    PMID: 31239796BACKGROUND
  • Ferede G, Tiruneh M, Abate E, Wondimeneh Y, Damtie D, Gadisa E, Howe R, Aseffa A, Tessema B. A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures. PLoS Negl Trop Dis. 2018 May 31;12(5):e0006430. doi: 10.1371/journal.pntd.0006430. eCollection 2018 May.

    PMID: 29852020BACKGROUND
  • Lilay A, Asamene N, Bekele A, Mengesha M, Wendabeku M, Tareke I, Girmay A, Wuletaw Y, Adossa A, Ba Y, Sall A, Jima D, Mengesha D. Reemergence of yellow fever in Ethiopia after 50 years, 2013: epidemiological and entomological investigations. BMC Infect Dis. 2017 May 15;17(1):343. doi: 10.1186/s12879-017-2435-4.

    PMID: 28506254BACKGROUND
  • Animut A, Mekonnen Y, Shimelis D, Ephraim E. Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. Jpn J Infect Dis. 2009 Mar;62(2):107-10.

    PMID: 19305049BACKGROUND
  • Kapasi AJ, Dittrich S, Gonzalez IJ, Rodwell TC. Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review. PLoS One. 2016 Aug 3;11(8):e0160278. doi: 10.1371/journal.pone.0160278. eCollection 2016.

    PMID: 27486746BACKGROUND
  • Self WH, Rosen J, Sharp SC, Filbin MR, Hou PC, Parekh AD, Kurz MC, Shapiro NI. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections. J Clin Med. 2017 Oct 7;6(10):94. doi: 10.3390/jcm6100094.

    PMID: 28991170BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

whole blood serum blood culture bottles

MeSH Terms

Conditions

Bacterial InfectionsVirus Diseases

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfections

Study Officials

  • Johan van Griensven, PhD, MD

    Institute of Tropical Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2020

First Posted

February 13, 2020

Study Start

June 1, 2019

Primary Completion

August 31, 2019

Study Completion

December 30, 2020

Last Updated

May 11, 2021

Record last verified: 2021-05

Locations